Skip to content

Lissencephaly 8 C4310646

Published: July 22, 2026Updated: August 20, 2026

A severe brain formation disorder where the brain surface lacks normal folds. It causes profound developmental delays and neurological problems. Care is supportive and focuses on managing complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Spastic quadriparesis

(neurologic)

Feeding difficulty requiring tube feeding

(neurologic)

Optic nerve hypoplasia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive seizure control

Aggressive antiepileptic drug management for lissencephaly-8, often requiring multiple medications and close titration to achieve adequate seizure control.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Multidisciplinary care coordination

Coordinated care involving neurology, developmental pediatrics, gastroenterology, and other specialties to address the complex needs of patients with lissencephaly-8.

monitoring

Additional treatment options

Vagus nerve stimulation evaluation

Surgical evaluation for vagus nerve stimulation as an adjunctive treatment for refractory seizures not controlled by medication alone.

surgical

Developmental and behavioral intervention

Behavioral and developmental therapies addressing cognitive delays, challenging behaviors, and promoting skill development appropriate to functional level.

psychological

Ketogenic diet consideration

Evaluation for ketogenic diet therapy as an alternative or adjunctive treatment for seizure control, particularly in medication-resistant cases.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Lissencephaly 8 C4310646?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Lissencephaly 8 C4310646. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy